TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NEO

NeoGenomics Inc

Healthcare · Diagnostics & Research

19.40$ -2.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow NEO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-32.3% +235.9% -16.0% +148.3% -47.8% -93.8% -1,930.3% -25.5%
+26.6% +225.0% -2.7% -3.8% +39.3% +18.0% +49.4% +30.1% +4.5% 0.0% -6.5%
+402.7% +56.3% +18.4% +8.0% +43.8% +2.1% +119.9% +9.9% -0.2% +35.6% +23.7%
+69.2% +310.9% +23.4% -73.7% +58.4% +18.6% -634.5%
-359.1%
-41.3% +240.2% +81.7% +4.5% +40.0% +45.3% +120.4% -51.8% -6.9% +42.8% -34.2%
+682.7% -91.3% +110.6% +920.4% -85.9% +712.2% +296.6% +14,736.9% -83.2% -196.0%
-100.0%
-97.5% -5,982.4% -2,037.2% +81.3% -25.8% -16.5%
-55.9% -126.3% -69.5% +160.4% +241.9% -100.2% -100.0%
+101.7% -144.2% -84.2% +73.4% +47.7% +207.8% -98.4% -61.5% +2.0% -4,411.0%
-135.6% -1,116.9% -52.4% -14.7% -181.0% -69.1% -945.7%
-26.4% +233.7% -68.8% +601.1% -89.0% -927.4%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?